Clinical
Article
Daptomycin/fosfomycin: A new standard for MRSA bacteremia?
Better survival was seen for MRSA bacteremia at 7 days using the combo vs. monotherapy.
News
FDA clears Abbott’s Influenza A & B 2, Strep A 2 assays
News
Length of stay, complications predict readmission for cirrhosis patients
PHILADELPHIA – Patients with cirrhosis have a higher risk of hospital readmission if their length of stay is less...
News
FDA approves Xofluza for treatment of influenza
News
Stroke risk in elderly following AMI extends to 12 weeks
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.
News
Drug overdose deaths down since late 2017
Longer-term trend, however, shows an increase of 2.7% during the 12 months ending in March 2018, compared with March 2017.
Clinical
Reducing alarm fatigue
A centralized monitoring system might help reduce unimportant alarms with no increase in cardiopulmonary arrest events.
News
Readmission to non-index hospital following acute stroke linked to worse outcomes
ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.
News
Blood test may obviate need for head CTs in brain trauma evaluation
SAN DIEGO – A biomarker blood test to evaluate patients for suspected TBI was associated with a high negative predictive value in a large trial....
News
DAPT’s benefit after stroke or TIA clusters in first 21 days
MONTREAL – The superiority of clopidogrel plus aspirin over aspirin alone was apparent only during the first 21 days of treatment.